Holen Sie sich die Stockscreener-App
6.15
1.49%
0.09
Handel nachbörslich:
6.12
-0.03
-0.49%
Schlusskurs vom Vortag:
$6.06
Offen:
$6
24-Stunden-Volumen:
549.98K
Relative Volume:
0.71
Marktkapitalisierung:
$437.42M
Einnahmen:
$11.40B
Nettoeinkommen (Verlust:
$-95.73M
KGV:
-3.0905
EPS:
-1.99
Netto-Cashflow:
$-64.37M
1W Leistung:
-4.65%
1M Leistung:
+10.41%
6M Leistung:
-38.50%
1J Leistung:
+99.03%
1-Tages-Spanne:
$5.95
$6.16
1-Wochen-Bereich:
$5.87
$6.625
52-Wochen-Spanne:
$2.41
$12.22
Mind Medicine Inc Stock (MNMD) Company Profile
Firmenname
Mind Medicine Inc
Sektor
Branche
Telefon
212-220-6633
Adresse
ONE WORLD TRADE CENTER, NEW YORK
Mind Medicine Inc Stock (MNMD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-12-09 | Fortgesetzt | ROTH Capital | Buy |
| 2022-11-16 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-08-26 | Eingeleitet | Oppenheimer | Outperform |
| 2022-08-10 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2022-05-04 | Eingeleitet | ROTH Capital | Buy |
| 2021-06-28 | Eingeleitet | Maxim Group | Buy |
Alle ansehen
Mind Medicine Inc Aktie (MNMD) Neueste Nachrichten
Mind Medicine: Two Pathways Created From One Pipeline Clinical Candidate (NASDAQ:MNMD) - Seeking Alpha
Mind Medicine (MindMed) (MNMD) to Release Quarterly Earnings on Thursday - MarketBeat
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Receives Average Recommendation of "Buy" from Brokerages - MarketBeat
MNMDMind Medicine (MindMed) Inc. Common Shares Latest Stock News & Market Updates - StockTitan
MindMed to Host Conference Call and Webcast to Discuss Third Quarter 2024 Financial Results and Provide Business Update - The Globe and Mail
FDA is said to see “path forward” for ecstasy-based drug (DRUG:NASDAQ) - Seeking Alpha
MindMed announces exchange agreement with investors By Investing.com - Investing.com
Bright Minds rally ends as psychedelic stocks extend volatility - MSN
Bright Minds stock cools amid psychedelic volatility (DRUG:NASDAQ) - Seeking Alpha
(MNMD) Investment Analysis and Advice - Stock Traders Daily
Mind Medicine (MindMed) (NASDAQ:MNMD) Stock Rating Upgraded by Leerink Partnrs - MarketBeat
Mind Medicine (MindMed) (NASDAQ:MNMD) Coverage Initiated at Leerink Partners - MarketBeat
Mind Medicine assumed with an Outperform at Leerink - Yahoo Finance
Trend Tracker for (MNMD) - Stock Traders Daily
"TNT Radio" Jeff Ghaemaghamy on Mind Medicine with Charles Kovess28 January 2024 (Podcast Episode 2024)News - imdb
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Given Consensus Recommendation of "Buy" by Analysts - MarketBeat
MindMed's SWOT analysis: psychedelic stock's potential in anxiety treatment - Investing.com
Marshall Wace LLP Has $15.58 Million Stock Position in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) - MarketBeat
Mind Medicine's chief medical officer sells shares worth over $41,000 By Investing.com - Investing.com UK
MindMed executive sells over $26k in company stock By Investing.com - Investing.com South Africa
Mind Medicine's chief medical officer sells shares worth over $41,000 - Investing.com
Generalized Anxiety Disorder Pipeline Trends 2024: Clinical Trials, Therapeutic Innovations, MOA, ROA by DelveInsight | Pfizer Inc., GlaxoSmithKline, Eli Lilly and Company, MindMed, VistaGen Pharma - Barchart
Rhumbline Advisers Makes New $679,000 Investment in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) - MarketBeat
Generalized Anxiety Disorder Global Market is Booming Across - openPR
(MNMD) Proactive Strategies - Stock Traders Daily
Mankind Pharma: Rs 10000 crore fund raise via this routeDetails - ET Now
Mankind Pharma to raise up to ₹10,000 crore through NCDs - CNBCTV18
Mankind Pharma board approves up to Rs 10,000-crore fund raise via NCDs, CPs - Moneycontrol
Mount Sinai Opens New Psychedelic Research Center in NYC - Mirage News
Psychedelic research at a crossroads - Science
Director GRYSKA DAVID W acquired 3,500 shares of Mind Medicine Inc [MNMD] - Knox Daily
Bank of New York Mellon Corp Buys 203,216 Shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) - MarketBeat
Wall Street analysts’ outlook for Mind Medicine Inc (MNMD) - SETE News
Examining the Potential Price Growth of Mind Medicine Inc (MNMD) - Knox Daily
Long Strange Trip Continues for Psychedelics in PTSD, TRD - Managed Healthcare Executive
A closer look at Mind Medicine Inc (MNMD)’s stock price trends - US Post News
Mind Medicine (MindMed) (NASDAQ:MNMD) Given New $14.00 Price Target at Canaccord Genuity Group - Defense World
Mannkind Corp (MNKD) gets rating Resumed from Leerink Partners - Knox Daily
Mind Medicine (MindMed) (NASDAQ:MNMD) PT Lowered to $14.00 at Canaccord Genuity Group - MarketBeat
MindMed Issues New Employee Share Options - TipRanks
MindMed Announces New Employee Inducement Grants - Business Wire
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Given Average Rating of "Buy" by Analysts - MarketBeat
MindMed Showcases Innovation at Investor Events - TipRanks
MindMed to Participate in September Investor Conferences - StockTitan
Mind Medicine (MindMed) Inc. Expected to Earn Q3 2024 Earnings of ($0.27) Per Share (NASDAQ:MNMD) - MarketBeat
Mind Medicine (MindMed) (NASDAQ:MNMD) Price Target Raised to $55.00 - MarketBeat
(MNMD) Long Term Investment Analysis - Stock Traders Daily
Mind medicine director David Gryska buys $20,930 in company shares By Investing.com - Investing.com Canada
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Director Acquires $20,930.00 in Stock - MarketBeat
Mind medicine director David Gryska buys $20,930 in company shares - Investing.com India
Mind Medicine Inc’s $75 Million Common Shares Offering - Global Legal Chronicle
Finanzdaten der Mind Medicine Inc-Aktie (MNMD)
Umsatz
Nettogewinn
Free Cashflow
ENV
Mind Medicine Inc-Aktie (MNMD) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Liao Carrie | Chief Accounting Officer |
Sep 25 '24 |
Sale |
5.98 |
2,352 |
14,065 |
99,543 |
| Barrow Robert | Chief Executive Officer |
Sep 25 '24 |
Sale |
5.98 |
19,771 |
118,231 |
545,772 |
2.02%
0.47%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):